The CAR-T field for oncology is saturated with an abundance of companies battling to capitalize on this new era for cell therapy. Get ahead of the curve by joining forward-thinking researchers pioneering CAR-T drug development in areas of great clinical potential, to strategically inform your future R&D decisions.

The CAR-T Beyond Oncology Digital Event is the first and only meeting to recognise the future potential of this field, highlighting in one day the groundbreaking clinical advancements and proof of concept work in areas including fibrosis, HIV and the CNS, to outline the new disease areas that CAR-T could achieve clinical benefit.

This first of its kind meeting will allow you to make educated and informed decisions when building your R&D platforms and future growth strategies, whilst providing you with the chance to connect and collaborate with those trailblazing this new area of development, including Cabaletta Bio, UCLA & Atara Biotherapeutics. 

Leave equipped with the latest view of the state of play in this emerging field and understand the curative potential of CAR-T therapies in autoimmunity, infection, and inflammation.